Skip to main content
Cancer Explained
Donate
Beginner 7 min readSource checked

FOLFIRINOX Chemotherapy Day by Day

FOLFIRINOX Day by Day explains why the regimen may be discussed, what to ask before day one, and which side effects to clarify.

NCI source

National Cancer Institute PDQ - Pancreatic Cancer Treatment (Health Professional Version)

A woman laughs with a nurse during an infusion, IV line visible
A woman laughs with a nurse during an infusion, IV line visible

Key fact

FOLFIRINOX Day by Day is a planning topic, not a diagnosis or treatment instruction by itself.

The short answer

FOLFIRINOX is a multi-drug chemotherapy regimen often discussed for pancreatic cancer and some other gastrointestinal cancers.

  • FOLFIRINOX Day by Day is a planning topic, not a diagnosis or treatment instruction by itself.

  • The next step depends on diagnosis, symptoms, goals, prior results, and what is still pending.

  • Use the page to prepare specific questions for a clinician who can review the full record.

Choose how you want to understand this

The full explanation.

What the letters stand for

FOLFIRINOX is not one drug. It is four, and the name is built from their initials:

  • FOL is folinic acid, also called leucovorin. It is not a chemo drug. It is a vitamin-like helper that locks fluorouracil onto its target enzyme so the chemo works harder.
  • F is fluorouracil, usually written 5-FU. It jams the enzyme cells use to make thymidine, one of the DNA building blocks.
  • IRIN is irinotecan. It blocks topoisomerase I, an enzyme that untangles DNA during copying. Without it, the strands break.
  • OX is oxaliplatin. It is a platinum drug that cross-links DNA so it cannot be read.

The regimen was built for pancreatic adenocarcinoma and is also used in some other gut cancers. It is demanding. The trial that put it on the map only enrolled people with an ECOG performance status of 0 or 1, meaning fully active or limited only in heavy work.

Day 1: about six hours in the chair

One cycle is 14 days, not 21. Day 1 is the long day.

Before anything runs, you get anti-nausea medicine. Because irinotecan can trigger a cholinergic reaction during the infusion (cramping, sweating, watery eyes, runny nose, sudden diarrhea), teams often give atropine, by vein or as a small injection under the skin, either up front or the moment symptoms start. The nurse draws up the amount.

The drugs in the original regimen studied in metastatic disease were:

  • Oxaliplatin, infused over about 2 hours
  • Irinotecan
  • Leucovorin, which sharpens the effect of the 5-FU
  • 5-FU, pushed quickly through the line
  • 5-FU again, running continuously over the next 46 hours

Every one of these is worked out from your height and weight by the chemotherapy pharmacy, and trimmed for blood counts and side effects, so the amounts on your own treatment sheet will not match anybody else's.

Add access time, flushes, and the pump hookup, and day 1 typically runs five to seven hours. Almost everyone gets a port or a PICC line first, because the 46-hour infusion has to run through a central vein.

Days 2 and 3: the pump goes home with you

The last 5-FU dose does not finish at the clinic. You leave wearing a small pump, often a balloon-type elastomeric pump in a pouch, that pushes 5-FU slowly for 46 hours. You shower with the site covered, you sleep with it, and you come back on day 3 to have it disconnected.

Know two things before you walk out. First, where the clamp is and what to do if the tubing leaks or the line pulls. Second, the phone number for the on-call service, not just the daytime clinic.

Days 3 to 14: the dip and the climb

White cells usually bottom out in the second week. In the metastatic trial, 5.4 percent of people on FOLFIRINOX developed febrile neutropenia, meaning fever with a dangerously low neutrophil count. Many teams add pegfilgrastim or filgrastim, growth-factor shots that push the marrow to make neutrophils faster. In the adjuvant PRODIGE-24 trial, 62.2 percent of people on the regimen needed growth factor.

Fatigue is usually worst on days 3 to 6, then eases enough that many people feel close to normal by day 10, just in time to start again.

Two different diarrheas, two different responses

Irinotecan causes diarrhea in two distinct patterns, and the label treats them separately.

Early diarrhea starts during or shortly after the infusion. It is the cholinergic reaction. It is usually short-lived and responds to atropine.

Late diarrhea starts more than 24 hours after the dose and can be life threatening. The label wants loperamide (Imodium) in your house before day 1, not fetched afterward. The regimen it gives is 4 mg at the first loose stool, then 2 mg every 2 hours until you have gone 12 hours with no diarrhea. Overnight you may take 4 mg every 4 hours. Do not run these high doses past 48 hours straight, because of the risk of paralytic ileus, a stalled bowel. Go by the loperamide instructions your own team wrote for you, not by the figures above — they are the label's reference regimen, printed here so you can see why the tablets need to be in the cupboard before day 1 and why the first loose stool is the moment to start.

If diarrhea comes with fever or a very low neutrophil count, the label calls for antibiotics, not just anti-diarrheals. That is a hospital decision, so call.

Genetics that change your dose

Irinotecan is cleared by an enzyme called UGT1A1. Some people carry gene variants that make less of it. The label names UGT1A1*28/*28, *6/*6, and *6/*28 as genotypes with a higher risk of severe neutropenia. A blood test can check this. Ask whether your center tests before cycle 1, because a positive result can mean a lower starting irinotecan dose.

Cold hurts for a few days

Oxaliplatin causes an unusual acute nerve effect. Cold triggers pins and needles, numbness, or an odd tight feeling in the hands, feet, around the mouth, or in the throat. Some people get a frightening sensation of throat tightness after a cold drink, without any real wheeze or stridor.

So for the first several days after each infusion: no ice in drinks, no ice cubes, no cold drinks straight from the fridge, gloves for the freezer aisle, and warm water for washing. The effect fades between cycles at first. Over many cycles a longer-lasting numbness can build up, and that is the reason oxaliplatin often gets stopped before the other three drugs do.

What the numbers behind the regimen look like

In metastatic pancreatic cancer, FOLFIRINOX gave a median overall survival of 11.1 months compared with 6.8 months for gemcitabine alone, and median progression-free survival of 6.4 versus 3.3 months.

After surgery, PRODIGE-24 compared 12 cycles of a modified FOLFIRINOX (the same four drugs, with a lower irinotecan amount and no rapid 5-FU push) against six cycles of gemcitabine. Median overall survival was 53.5 months versus 35.5, and 5-year survival was 43.2 percent versus 31.4 percent. The cost was real: grade 3 or 4 side effects hit 75.9 percent on FOLFIRINOX versus 52.9 percent on gemcitabine, and 33 percent stopped early.

When to get help sooner

  • Call 911 or go to an emergency department if throat tightness or trouble swallowing does not ease within a few minutes, or you cannot catch your breath.
  • Ring your oncology team straight away, day or night, if any fever reaches 100.4 F (38 C) while you are on treatment, or chills set your teeth chattering; if they cannot be reached fast, go to an emergency department and tell them you are on FOLFIRINOX. Do not leave it until the clinic opens. Febrile neutropenia is the reason this regimen comes with growth-factor shots, and CDC calls a fever during chemotherapy a medical emergency.
  • Call your care team the same day if diarrhea is still going after 24 hours of loperamide, you pass six or more loose stools above your normal in a day, or fluids will not stay down.
  • Call your care team the same day if you have passed no urine for 8 hours, or you go dizzy on standing.
  • Call your care team the same day if the pump alarms, leaks, or the line works loose.

Chemotherapy, How Chemotherapy Is Given, Diarrhea During Cancer Treatment, Fever During Chemo, and Low White Blood Cells During Chemotherapy.

Sources

Words to know

Tap any term to see what it means.

Browse the full glossary →

An older woman and female clinician look over medication bottles, smiling

Common questions

Does this page tell me what treatment to choose?

No. It explains the topic in plain language so you can ask better questions. Your care team applies it to your diagnosis, test results, and goals.

What should I bring to the visit?

Bring the report, medicine list, recent test results, and a written list of questions. Ask what result or decision is still pending.

When is this more urgent?

Use the urgent instructions from your care team for severe, fast-changing, or treatment-specific warning symptoms.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Your next step

Turn this topic into questions for your next appointment.

Build a question list
Human Connection Layer

Speak With Trained Specialists & Human Navigators

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.

Help Us Improve This Guide

Did this explanation answer your question and help you determine your next step?

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Sources last checked: 2026-08-13 what this meansLast updated: 2026-08-19Next planned review: 2027-01-21

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Source checked This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.

Still have questions?

Educational answers, plain language

Ask Cancer Explained

Doctor Visit Prep Tool

Get a personalized list of questions to ask about this topic.

Start the guide

Related learning map

How this explanation connects to 9 other things you can explore — related topics, terms, questions, practice, and its NCI source.

FOLFIRINOX Chemotherapy Day by Day